Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Barclays | 2.82% | $639.11K | $89.96B | 105.44% | 77 Outperform | |
| Banco Santander SA | 2.78% | $629.25K | $175.03B | 158.22% | 72 Outperform | |
| Aercap Holdings | 2.55% | $578.89K | $25.98B | 56.36% | 77 Outperform | |
| Mitsubishi UFJ | 2.41% | $546.68K | $187.09B | 42.32% | 77 Outperform | |
| ING Groep | 2.38% | $538.80K | $80.46B | 80.96% | 72 Outperform | |
| Marubeni | 2.37% | $537.39K | $48.83B | 107.30% | 70 Outperform | |
| NatWest Group | 2.31% | $523.07K | $68.85B | 89.07% | 81 Outperform | |
| Fujitsu | 2.28% | $517.44K | $50.51B | 57.12% | 74 Outperform | |
| Teva Pharmaceutical | 2.13% | $482.03K | $37.89B | 55.25% | 63 Neutral | |
| Novartis | 2.05% | $465.26K | $271.04B | 42.77% | 80 Outperform |